#evaluate(de(' #AdditionalMetaTags# '))#
Venturelab
close

Solutions for Antiphospholipid Syndrome

Endotelix Diagnostics Sàrl

Swiss Startup - Endotelix Diagnostics Profile Main Image
Incorporated
07.01.2019
Headquarters
Genève
Support

Endotelix is a spin-off from the University of Geneva and dedicated to providing fast, sensitive and reliable solutions for Antiphospholipid Syndrome including diagnostic tests and treatment options. We are currently developing a new diagnostic test to measure the circulating levels of antiphospholipid antibodies (aPL) as a rapid test (LFA-like). It allows the measuring of anti-ß2GP1 IgG and IgM. This diagnostic test is more sensitive and faster than the current assays. We have also developed an ELISA test for hospital and Research Use Only.

Milestones news

31.01.2024

Seed Funding Round

30.06.2023

Full Clinical Validation of Endotelix's Technology

Documents

Swiss Startup - Endotelix Diagnostics Product Image Swiss Startup - Endotelix Diagnostics Team Image Swiss Startup - Endotelix Diagnostics Additional Image

Videos and Presentations

A Kickers' World, Episode 5 Endotelix CEO Karim Brandt